Literature DB >> 25193301

Suppression of peritoneal thickening by histamine in a mouse model of peritoneal scraping.

Keyue Liu1, Toshihiro Yorozuya, Naoto Adachi, Atsuko Motoki, Kanji Ninomiya, Hisao Mabuchi, Noriyuki Iwamoto, Masahiro Nishibori.   

Abstract

BACKGROUND: Inflammatory reactions play an important role in peritoneal sclerosis in patients on peritoneal dialysis. Since histamine affects inflammatory reactions and immune responses, we investigated effects of intraperitoneal administration of histamine on peritonitis induced by mechanical scraping in mice.
METHODS: After anesthesia, the right peritoneum was scraped 90 times over 1 min, and bilateral peritonea were observed by light microscopy after 7 days.
RESULTS: Thickness of the peritoneal membrane on the right side was 174 ± 77 µm (mean ± SD, n = 8), while that on the left side was 24 ± 19 µm. Intraperitoneal administration of histamine (0.3 or 1.0 mmol/L, 0.5 mL each) twice daily for 7 days after scraping decreased thickness of the right peritoneum to 42 and 43 % of that in saline-injected animals, respectively (P < 0.01), although histamine (0.1 mmol/L) did not affect it. Promethazine (5 nmol, twice daily for 7 days), a histamine H1 receptor antagonist, abolished the amelioration caused by histamine (1.0 mmol/L). Neither ranitidine (15 nmol), a histamine H2 receptor antagonist, nor thioperamide (7.5 nmol), a histamine H3/H4 receptor antagonist, affected the outcome in histamine-treated mice.
CONCLUSION: These findings indicate that histamine H1 action partly prevents the development of peritoneal fibrosis caused by mechanical scraping.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25193301     DOI: 10.1007/s10157-014-1027-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  18 in total

1.  Mast cells are required for normal healing of skin wounds in mice.

Authors:  Karsten Weller; Kerstin Foitzik; Ralf Paus; Wolfgang Syska; Marcus Maurer
Journal:  FASEB J       Date:  2006-09-11       Impact factor: 5.191

Review 2.  Cerebral ischemia and brain histamine.

Authors:  Naoto Adachi
Journal:  Brain Res Brain Res Rev       Date:  2005-09-21

3.  Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.

Authors:  Ralf Gutzmer; Carola Diestel; Susanne Mommert; Brigitta Köther; Holger Stark; Miriam Wittmann; Thomas Werfel
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

4.  Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients.

Authors:  M Numata; M Nakayama; T Hosoya; C M Hoff; C J Holmes; M Schalling; L Nordfors; B Lindholm
Journal:  Clin Nephrol       Date:  2004-12       Impact factor: 0.975

Review 5.  Advanced glycation end-products and peritoneal sclerosis.

Authors:  Sakurako Nakamura; Toshimitsu Niwa
Journal:  Semin Nephrol       Date:  2004-09       Impact factor: 5.299

6.  Mast cell degranulation is essential for anastomotic healing in well perfused and poorly perfused rat colon.

Authors:  John Coneely; Rory Kennelly; D Bouchier-Hayes; Desmond C Winter
Journal:  J Surg Res       Date:  2010-05-21       Impact factor: 2.192

7.  Suppression of ischemia/reperfusion liver injury by histamine H4 receptor stimulation in rats.

Authors:  Naoto Adachi; Keyue Liu; Atsuko Motoki; Masahiro Nishibori; Tatsuru Arai
Journal:  Eur J Pharmacol       Date:  2006-06-29       Impact factor: 4.432

8.  The role of histamine in wound healing. II. The effect of antagonists and agonists of histamine receptors (H1 and H2) on collagen levels in granulation tissue.

Authors:  R Dabrowski; C Maśliński
Journal:  Agents Actions       Date:  1981-04

9.  A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens.

Authors:  Y Itoh; R Oishi; N Adachi; K Saeki
Journal:  J Neurochem       Date:  1992-03       Impact factor: 5.372

10.  Suppression of ischaemia-induced cytokine release by dimaprit and amelioration of liver injury in rats.

Authors:  Atsuko Motoki; Naoto Adachi; Keyue Liu; Hideo K Takahashi; Masahiro Nishibori; Toshihiro Yorozuya; Tatsuru Arai; Takumi Nagaro
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-02-29       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.